Perceived risk of gastric cancer associated with long-term use of proton pump inhibitors: Bridging the gap

Table 1 Demographics of participants

Characteristics	n = 33
Medical specialty
Gastroenterologist	15 (45.0)
Non-gastroenterologists	18 (55.0)
Years of experience
< 10	24 (26.3)
10-20	34 (37.4)
> 20	33 (36.3)
Gender
Male	42 (46.0)
Female	49 (54.0)
Geographical region
North	48 (53.0)
Center	33 (36.0)
South	10 (11.0)

Data are presented as n (%).

Table 2 Responses of gastroenterologists vs non-gastroenterologists

Characteristic	Gastro (n = 15)	Non-gastro (n = 18)	P value	Together (n = 33)
Have prescribed long-term PPI	15 (100)	14 (74)	0.0400a	29 (87)
Aware of gastric cancer risk	15 (100)	7 (38)	0.0001b	22 (66)
Will prescribe long-term PPI	14 (93)	12 (66)	0.0800	25 (75)

^aP < 0.05.

^bP < 0.01.

PPI: Proton pump inhibitors; Gastro: Gastroenterologist; Non-gastro: Non-gastroenterologist.